Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Old National Bancorp
ONB
$10.3B
| $3.79M | ﹤0.01% |
310,590
+71,790
| +30% | +$847K |
|
2902
Quad
QUAD
$545M
| $3.78M | ﹤0.01% |
292,143
+1,535
| +0.5% | +$16.6K |
|
2903
Vermilion Energy
VET
$1.75B
| $3.78M | ﹤0.01% |
129,223
-54,742
| -30% | -$1.47M |
|
|
ARIA
2904
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.77M | ﹤0.01% |
590,462
+206,616
| +54% | +$1.16M |
|
2905
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$52.6B
| $3.76M | ﹤0.01% |
149,716
-936
| -0.6% | -$22.3K |
|
2906
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.15B
| $3.75M | ﹤0.01% |
72,012
| – | – |
|
2907
Invesco Preferred ETF
PGX
$3.81B
| $3.75M | ﹤0.01% |
251,103
+209,851
| +509% | +$3.09M |
|
2908
PUT
PACCAR
PCAR
$70.4B
| $3.75M | ﹤0.01% |
102,750
+77,100
| +301% | +$2.58M |
|
2909
ATI
ATI
$25.7B
| $3.75M | ﹤0.01% |
229,757
+28,342
| +14% | +$345K |
|
|
ASXC
2910
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
| $3.74M | ﹤0.01% |
67,692
-144,708
| -68% | -$6.2M |
|
2911
CALL
Baxter International
BAX
$14.2B
| $3.74M | ﹤0.01% |
91,000
-157,900
| -63% | -$6.02M |
|
|
PMC
2912
DELISTED
PharMerica Corporation
PMC
| $3.74M | ﹤0.01% |
169,053
-16,884
| -9% | -$449K |
|
2913
PUT
Teck Resources
TECK
$29.2B
| $3.74M | ﹤0.01% |
490,900
-32,100
| -6% | -$174K |
|
|
TSL
2914
DELISTED
Trina Solar Limited
TSL
| $3.73M | ﹤0.01% |
375,713
-18,760
| -5% | -$186K |
|
2915
PUT
Mattel
MAT
$4.41B
| $3.73M | ﹤0.01% |
110,900
+10,000
| +10% | +$304K |
|
2916
PUT
Corning
GLW
$121B
| $3.73M | ﹤0.01% |
178,300
-2,556,400
| -93% | -$47.4M |
|
|
AMTD
2917
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3.72M | ﹤0.01% |
118,000
+80,400
| +214% | +$2.37M |
|
2918
PUT
Vertex Pharmaceuticals
VRTX
$120B
| $3.72M | ﹤0.01% |
46,800
-2,700
| -5% | -$244K |
|
|
ALIM
2919
DELISTED
Alimera Sciences
ALIM
| $3.72M | ﹤0.01% |
141,656
+33,951
| +32% | +$1.06M |
|
|
JWN
2920
CALL
DELISTED
Nordstrom
JWN
| $3.71M | ﹤0.01% |
64,900
-242,800
| -79% | -$12.5M |
|
|
VG
2921
DELISTED
Vonage Holdings Corporation
VG
| $3.71M | ﹤0.01% |
812,659
-166,326
| -17% | -$822K |
|
|
DNY
2922
PUT
DELISTED
DONNELLEY R R & SONS CO
DNY
| $3.69M | ﹤0.01% |
225,100
+222,100
| +7,403% | +$3.64M |
|
2923
ACI Worldwide
ACIW
$5.86B
| $3.69M | ﹤0.01% |
177,330
+53,379
| +43% | +$1M |
|
|
ALDR
2924
PUT
DELISTED
Alder Biopharmaceuticals
ALDR
| $3.67M | ﹤0.01% |
+150,000
| New | +$3.47M |
|
|
FCB
2925
DELISTED
FCB Financial Holdings, Inc.
FCB
| $3.67M | ﹤0.01% |
110,207
-32,821
| -23% | -$1.05M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.